-
FDA Clears Insulet's Omnipod 5 Automated Insulin Delivery System For Preschool Children
Monday, August 22, 2022 - 7:39am | 199Read More...The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ: PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D). Omnipod 5 is the first tubeless AID system in the United States that...
-
Lantern Pharma Gets FDA Clearance for Mid-Stage Lung Cancer Study
Thursday, July 14, 2022 - 9:31am | 260Read More...The Food and Drug Administration (FDA) has announced clearance to Lantern Pharma (NASDAQ: LTRN) to proceed with Phase 2 clinical trial of its investigational new drug LP-300 in combination with chemotherapy for never smoker patients with advanced non-small cell lung cancer (NSCLC)....
-
Oculus Innovative Sciences Surges 26%: Here's Why
Wednesday, April 20, 2016 - 2:35pm | 268Read More...Shares of Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) surged higher by more than 26 percent on Wednesday after the company announced it has received a new 510(k) clearance from the U.S. Food and Drug Administration for its Microcyn®-based Lasercyn™ Gel. Oculus Innovative is a...
-
NeuroMetrix Announces FDA Clearance For Upgraded Version Of Quell, Shares Surge
Wednesday, January 6, 2016 - 2:22pm | 199Read More...Shares of Neurometrix Inc (NASDAQ: NURO), a healthcare company that develops wearable medical technology, announced during CES 2016 it received clearance from the U.S. Food and Drug Administration for an upgraded version of Quell, a chronic pain relief wearable. Neurometrix also confirmed the...
